By reporting side effects you can help provide more information on thesafety of this medicine
You shouldnt just eat protein from one source, either
Conclusions/interpretation Approximately half of type 2 diabetes patients who had started using GLP-1 receptor agonists or SGLT2 inhibitors had discontinued treatment within 5 years of follow-up
1, 9 Nov
It is noteworthy that such beneficial effects (counteraction of increased MDA values along with the distinctive effect on NO and eNOS) and a general lack of toxicity [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] would also be instructive for all metabolites, and therefore metabolites would also participate in the noted beneficial effects (see Section 1)